Key Events This Week
13 Apr: Stock opens at Rs.693.75, gains 0.69% despite Sensex decline
15 Apr: MarketsMOJO upgrades rating to Sell; stock rises 1.27%
16 Apr: Technical momentum shifts; stock dips 0.44% amid mixed signals
17 Apr: Week closes at Rs.696.60, down 0.41% on the day

Aarti Pharmalabs Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges
2026-04-16 08:49:39Aarti Pharmalabs Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 15 April 2026, driven primarily by a shift in technical indicators despite ongoing financial challenges. The company’s Mojo Score now stands at 31.0, reflecting a cautious but slightly more favourable outlook amid persistent operational headwinds and valuation considerations.
Read full news article
Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-04-16 08:08:02Aarti Pharmalabs Ltd has exhibited a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting nuanced changes in key indicators such as MACD, RSI, and moving averages. Despite a modest day gain of 1.10%, the stock’s technical signals present a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector.
Read full news article
Aarti Pharmalabs Ltd is Rated Strong Sell
2026-04-05 10:10:30Aarti Pharmalabs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Aarti Pharmalabs Ltd Surges 7.05% to Day's High of Rs 632.55 — Outperforms Sector by 5.98 Percentage Points
2026-04-01 12:01:14The Sensex declined by 2.11% on 1 Apr 2026, while Aarti Pharmalabs Ltd surged 7.05%, marking a remarkable 5.98 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This strong single-session gain stands out as a stock-specific event amid a broadly weak market environment.
Read full news article
Aarti Pharmalabs Ltd is Rated Strong Sell
2026-03-25 10:10:42Aarti Pharmalabs Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 02 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Aarti Pharmalabs Ltd is Rated Strong Sell
2026-03-14 10:10:32Aarti Pharmalabs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news articleAarti Pharmalabs Declines 3.31%: 3 Key Factors Driving the Weekly Downtrend
2026-03-07 11:03:54
Key Events This Week
2 Mar: Stock opens with a sharp gap down amid market concerns
2 Mar: Downgrade to Strong Sell by MarketsMOJO due to weak financials and bearish technicals
4 Mar: Technical momentum shifts further bearish with deteriorating indicators
6 Mar: Week closes at Rs.699.45, down 3.31%
Corporate Actions
No Upcoming Board Meetings
Aarti Pharmalabs Ltd has declared 30% dividend, ex-date: 16 Feb 26
No Splits history available
No Bonus history available
No Rights history available







